Traduction de «opinion issued » (Néerlandais → Français) :

In the opinion issued by the SCF in 2003, 3 cans/day were considered a reasonable high (acute) consumption, corresponding to the average consumption mentioned in an Irish study as regards the highest number of cans consumed in a single drinking session (SCF, 2003) The SCF has also pointed out that in two inquiries mention is made of a consumption of 8 to 12 cans a day by some extreme consumers.
Dans l’avis émis par le SCF en 2003, un nombre de 3 canettes/jour était considéré comme une consommation raisonnable élevée (aiguë) et correspondant à la moyenne rapportée dans une enquête irlandaise pour le nombre le plus élevé de canettes consommées en une séance unique (SCF, 2003). Le SCF a également indiqué qu’une consommation d’un nombre de 8 à 12 canettes par jour a été signalée par quelques consommateurs extrêmes dans deux enquêtes.

On a European level, the Scientific Committee on Food (SCF) issued a first opinion on caffeine, taurine and D-glucuronolactone as ingredients of energy drinks in 1999 (SCF, 1999).
Au niveau européen, le Scientific Committee on Food (SCF) a rendu en 1999 un premier avis concernant la caféine, la taurine et le D-glucuronolactone comme constituants des boissons énergisantes (SCF, 1999).

In 2007, 60 formal scientific opinions were issued, a number of which were further coordinated by the Belgian delegation in the SAWP.
In 2007, 60 formal scientific opinions were issued, a number of which were further coordinated by the Belgian delegation in the SAWP.

●● Efficacy: the active ingredient is as such subject to an authorisation or prequalification by the WHO or a positive opinion from the EMEA During this first year of activity, The Production & Distribution department issued 149 EDs.
●● Efficacy: the active ingredient is as such subject to an authorisation or prequalification by the WHO or a positive opinion from the EMEA During this first year of activity, The Production & Distribution department issued 149 EDs.

European Union regulatory approval is anticipated soon, after the Committee for Medicinal Products (CHMP) issued a positive opinion in May supporting approval in renal cell carcinoma following progression on VEGF-targeted therapy.
Dans l’Union européenne, l’autorisation est attendue sous peu dès lors que le Committee for Medicinal Products (CHMP) a émis un avis favorable soutenant l’homologation dans le carcinome des cellules rénales à la suite de la progression du traitement ciblé sur le VEGF.

In September, the CHMP issued a positive opinion recommending EU approval of Tasigna in this indication.
En septembre, le CHMP a émis un avis favorable à une autorisation de Tasigna par l’UE pour cette indication.